Quotient Limited to Participate in the Jefferies London Healthcare Conference
Quotient Limited (NASDAQ:QTNT) announced that its management team will present at the Jefferies London Healthcare Conference on November 16, 2021, at 8:40am GMT (3:40am ET). Interested parties can access a live webcast of the presentation through the investor relations section on Quotient's website, with a replay available for 90 days. Quotient, a company specializing in transfusion diagnostics, offers the MosaiQ platform, a revolutionary testing solution, including the COVID-19 Antibody Microarray, which has received CE marking and FDA Emergency Use Authorization.
- None.
- None.
JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT (3:40am ET).
A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.
About Quotient Limited
Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. In response to the global effort to combat COVID-19, Quotient developed the MosaiQ COVID-19 Antibody Microarray which is CE marked and has received the U.S. FDA Emergency Use Authorization. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.
The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.
Contact: IR@quotientbd.com; +41 22 545 52 26
FAQ
When will Quotient Limited present at the Jefferies London Healthcare Conference?
How can I access Quotient Limited's presentation at the Jefferies Conference?
What technology does Quotient Limited offer?
What is the status of the MosaiQ COVID-19 Antibody Microarray?
Where is Quotient Limited based?
